Worthy of further analysis

A recent report by Deloitte projects that the artificial intelligence (AI) drug discovery market will grow 53% by 2025, citing the increased investment of  labs in AI as a way to boost research but also to collect, analyze, and produce […]

Read More

New leadership, continued vision

Welcome to the first issue of Pharmaceutical Commerce under new ownership. As announced, MJH Life Sciences acquired the multimedia platform in July, after 15 years of careful stewardship by founder Nick Basta. In handing over the keys, Nick mentioned in […]

Read More

One door closes; another one opens…

Hello readers! The editorials that have run on this page in every issue of Pharmaceutical Commerce usually are cast as words from on high; this time it’s a little more personal. After 15 years, I’m giving up the editorship of […]

Read More

Two cheers for PCORI

In the mid-2000s, when Pharmaceutical Commerce was founded, the editors and writers spent a lot of time talking about how state-of-the-art computing and data analysis would revolutionize medicine. The thought was that as more patient data was collected and analyzed […]

Read More

Uplifting the patient care continuum

Welcome to our 5th annual report on patient support / hub services. Pharmaceutical Commerce has been highlighting this part of the life-sciences service universe for two reasons: one trivial and one profound. The trivial reason is that the topic fits […]

Read More

Gimme my data

A good way to get vendors involved in pharma cold-chain services and equipment looking sideways is to ask them to provide the data they collect during shipments and deliveries. In the frictionless, IoT (Internet of Things) world we are entering, […]

Read More